Eli Lilly & Co (NYSE: LLY) Q4 2020 earnings call dated Jan. 29, 2021
Corporate Participants:
Kevin Hern — Vice President of Investor Relations
David A. Ricks — Chairman and Chief Executive Officer
Joshua L. Smiley — Senior Vice President and Chief Financial Officer
Daniel M. Skovronsky — Senior Vice President and Chief Scientific Officer
Anne E. White — Senior Vice President and President of Lilly Oncology
Analysts:
Geoff Meacham — Bank of America — Analyst
Tim Anderson — Wolfe Research — Analyst
Umer Raffat — Evercore — Analyst
Steve Scala — Cowen and Company — Analyst
David Risinger — Morgan Stanley — Analyst
Daniel Ziment — Goldman Sachs — Analyst
Chris Schott — J.P. Morgan — Analyst
Seamus Fernandez — Guggenheim — Analyst
Andrew Baum — Citigroup — Analyst
Gregg Gilbert — Truist Securities — Analyst
Ronny Gal — Bernstein — Analyst
Vamil Divan — Mizuho Securities — Analyst
Carter Gould — Barclays — Analyst
Kerry Holford — Berenberg — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
Nvidia (NVDA) likely to report strong results once again, fueled by AI boom
Nvidia Corporation (NASDAQ: NVDA) has been at the forefront of the artificial intelligence revolution, developing high-tech AI chips that provide the computational power and efficiency required for training and deploying
What to expect when Lowe’s Companies (LOW) reports Q4 2024 earnings
Shares of Lowe’s Companies, Inc. (NYSE: LOW) stayed red on Tuesday. The stock has dropped 8% over the past three months. The home improvement retailer is slated to report its
MDT Earnings: Medtronic reports higher Q3 2025 revenue and adj. profit
Medical device maker Medtronic plc (NYSE: MDT) on Tuesday reported an increase in revenues and adjusted profit for the third quarter of 2025. Third-quarter earnings, excluding special items, rose 7%